Investigational Site Number: 8400001

Houston, Texas 77079

0 studies enrolling now · 4 studies all time

What they study most

Leukaemia, Plasma Cell Myeloma, T-cell Type Acute Leukemia-Precursor, T-lymphoblastic Lymphoma/Leukaemia, Type 1 Diabetes Mellitus-Type 2 Diabetes Mellitus

Studies at this site

• A Study to Investigate the Clinical Benefit of Isatuximab in Combination With Bortezomib, Lenalidomide and Dexamethasone in Adults With Newly Diagnosed Multiple Myeloma Not Eligible for Transplant — Running, not enrolling
• First in Human Testing of Dose-escalation of SAR440234 in Patients With Acute Myeloid Leukemia, Acute Lymphoid Leukemia and Myelodysplastic Syndrome — Stopped early
• Comparison of SAR341402 to NovoLog/NovoRapid in Adult Patients With Diabetes Mellitus Also Using Insulin Glargine — Completed
• Safety and Efficacy of Isatuximab in Lymphoblastic Leukemia — Stopped early